Miss JAZZ's $58.50 Secondary But Think It's A Steal At $55?

Looking back to 90 days ago, Jazz Pharmaceuticals plc (NASD: JAZZ) priced a 5,375,000 share secondary stock offering at $58.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 15.3% higher than the offering price.